ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in September 2021. Updated September 30, 2021.
A roundup of FDA’s actions in September 2021.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in September 2021. Updated September 30, 2021.
A roundup of FDA’s actions in September 2021.